NCT01891903UnknownNot Applicable
TO TRANSLATE AND VALIDATE THE ToPAS (TORONTO PSORIATIC SCREENING QUESTIONNAIRE) FOR THE SCREENING OF PSORIATHIC ARTHRITIS PATIENTS IN DERMATOLOGY CLINICS
Reumatologia Integral LTDA1 site in 1 country60 target enrollmentStarted: May 2013Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- The Kuder Richardson Coefficient of reliability (K-R 20)
Study Overview
Brief Summary
TO TRANSALETE AND VALIDATE DE TORONTO PSORIATIC ARTHRITIS SECREENING QUESTIONAIRE INTO SPANISH
Detailed Description
THIS IS PART OF THE COLOMBIAN REGISTRY OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS
Study Design
- Study Type
- Observational
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 16 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •ADULT WITH PSORIASIS IN THE DERMATOLOGY CLINIC
Exclusion Criteria
- •ADULT WITH OTHER AUTOIMMUNE DISEASE
Outcomes
Primary Outcomes
The Kuder Richardson Coefficient of reliability (K-R 20)
Time Frame: 4 MONTHS
Secondary Outcomes
No secondary outcomes reported
Investigators
Adriana Beltran
ADRIANA BELTRAN OSTOS
Reumatologia Integral LTDA
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Validation of COMPAT-SF Spanish TranslationChronic PancreatitisNCT06698302Methodist Health System100
Completed
Not Applicable
Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)CancerNCT01436240Memorial Sloan Kettering Cancer Center112
Unknown
Not Applicable
Validation of a Translation Into Spanish of the Oswestry Disability IndexLow Back PainNCT01649011American British Cowdray Medical Center150
Unknown
Not Applicable
Validation of a Translation Into Spanish (Mexico) of the Spinal Cord Independence Measure IIISpinal Cord InjuryNCT01785277American British Cowdray Medical Center100
Completed
Not Applicable
Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic TreatmentBipolar DisorderSchizophreniaNCT00692133AstraZeneca250
